Submitted by Anonymous (not verified) on 3 June 2026 - 14:10
Human medicines European public assessment report (EPAR): Sotyktu, deucravacitinib, Date of authorisation: 24/03/2023, Revision: 6, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Sotyktu, deucravacitinib, Date of authorisation: 24/03/2023, Revision: 6, Status: Authorised